Interplay of Hydropathy and Heterogeneous Diffusion in the Molecular Transport within Lamellar Lipid Mesophases

Abstract

Lipid mesophases are being intensively studied as potential candidates for drug-delivery purposes. Extensive experimental characterization has unveiled a wide palette of release features depending on the nature of the host lipids and of the guest molecule, as well as on the environmental conditions. However, only a few simulation works have addressed the matter, which hampers a solid rationalization of the richness of outcomes observed in experiments. Particularly, to date, there are no theoretical works addressing the impact of hydropathy on the transport of a molecule within lipid mesophases, despite the significant fraction of hydrophobic molecules among currently-available drugs. Similarly, the high heterogeneity of water mobility in the nanoscopic channels within lipid mesophases has also been neglected. To fill this gap, we introduce here a minimal model to account for these features in a lamellar geometry, and systematically study the role played by hydropathy and water–mobility heterogeneity by Brownian-dynamics simulations. We unveil a fine interplay between the presence of free-energy barriers, the affinity of the drug for the lipids, and the reduced mobility of water in determining the net molecular transport. More in general, our work is an instance of how multiscale simulations can be fruitfully employed to assist experiments in release systems based on lipid mesophases.

Lipidic drug delivery systems: is the microbiome a cause for concern?

“…The marked differences between these domains are key determinants of drug transport, thus ultimately affecting the release rate. 9 The liquid crystalline inverse cubic (V₂) or inverse hexagonal (H₂) nanostructures can be dispersed into solution in the presence of a stabiliser to create cubosomes or hexosomes respectively. 10 Their unique combination of biocompatibility, stability to dilution, dynamic self-assembled structure, and sustained drug release qualities make lipid mesophases an attractive drug delivery vehicle.…”